HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and new drug development. Its production line includes various core technologies required by the cell therapy industry to provide CMO (contracted production services) and CDMO (commissioned development and manufacturing services) and testing services. The company was founded by Cheng Han Wen on June 12, 2019 and is headquartered in Taoyuan, Taiwan.